Esther Martinborough
Vermögen: 291 621 $ am 30.06.2026
Vermögen: 291 621 $ am 30.06.2026
Esther Martinborough is currently an Independent Director at Codexis, Inc. since 2021 and a Director at San Diego Squared since 2021.
Former positions include Chief Scientific Officer at Escient Pharmaceuticals, Inc. from 2023 to 2024 and Executive Director-Research at Receptos LLC from 2015 to 2018.
Education includes a doctorate from the Swiss Federal Institute of Technology and graduate studies at the University of California.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CODEXIS, INC. 0.14% | 17.06.2026 | 129’036 ( 0.14% ) | 291 621 $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| CODEXIS, INC. | Direktor/Vorstandsmitglied | 02.02.2021 |
| Unternehmen | Position | Ende |
|---|---|---|
Escient Pharmaceuticals, Inc.
Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a drug discovery and development company | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2024 |
| RECEPTOS INC | Direktor/Vorstandsmitglied | 01.01.2015 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Codexis, Inc.
Codexis, Inc. Chemicals: SpecialtyProcess Industries Develops biocatalytic chemical processes | Process Industries |
Receptos LLC
Receptos LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapeutics in immune disease | Health Technology |
Swiss Federal Institute of Technology
Swiss Federal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California
University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Escient Pharmaceuticals, Inc.
Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a drug discovery and development company | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen